The applicability of WSI in NSCLC can effectively differentiate between histological subtypes and identify molecular alterations like STK11, EGFR, FAT1, SETBP1, KRAS, and TP53 mutations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.